Assessment of Liver Cancer Burden from 1990 to 2021 with Projections for 2040: Findings from the 2021 Global Burden of Disease Study - Top-Institutions - MDSpire

Assessment of Liver Cancer Burden from 1990 to 2021 with Projections for 2040: Findings from the 2021 Global Burden of Disease Study

  • By

  • Yong Xie

  • Tianshi Lyu

  • Haitao Guan

  • Li Song

  • Xiaoqiang Tong

  • Yinghua Zou

  • Min Yang

  • Jian Wang

  • April 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco (UCSF) Liver Center
    University of California, San Francisco (UCSF) Liver Center

    San Francisco, CA

    Key Differentiators

    • Hepatology
    • Oncology
    • Epidemiology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Hepatobiliary Surgery
    • Epidemiology

  • #3

    National Cancer Institute (NCI)
    National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Cancer Epidemiology
    • Public Health
    • Oncology

  • #4

    The Liver Cancer Institute, Zhongshan Hospital, Fudan University
    The Liver Cancer Institute, Zhongshan Hospital, Fudan University

    Shanghai, Shanghai

    Key Differentiators

    • Hepatology
    • Oncology
    • Virology

  • #5

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Stockholm

    Key Differentiators

    • Epidemiology
    • Hepatology
    • Public Health

Original Source(s)

Assessment of Liver Cancer Burden from 1990 to 2021 with Projections for 2040: Findings from the 2021 Global Burden of Disease Study

  • by Yong Xie, Tianshi Lyu, Haitao Guan, Li Song, Xiaoqiang Tong, Yinghua Zou, Min Yang, Jian Wang

  • April 29, 2026

Related Content

Changes in Bone Microarchitecture and Inflammatory Cytokines After Cure of Chronic Hepatitis C Infection With Direct-Acting Antiviral Therapy

Hepatitis C Treatment Outcomes for Patients With Infective Endocarditis Treated by an Interdisciplinary Team

Hepatitis C Treatment Initiation During Hospitalization for People Who Use Drugs: A Narrative Review of the Literature